Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Am J Public Health. 2010 Mar 18;101(1):112–119. doi: 10.2105/AJPH.2009.173112

TABLE 2.

Demographic and Clinical Characteristics of Colon Cancer Patients: Toronto, ON, and San Francisco, CA, 1996–2006

Toronto, No. (%) San Francisco, No. (%)

Age at diagnosis, y
 25–59 206 (22.2) 219 (21.6)
 60–69 242 (26.0) 231 (22.8)
 70–79 272 (29.2) 312 (30.8)
 ≥80 210 (22.6) 252 (24.9)
Women 466 (50.1) 505 (49.8)
Stage at diagnosisa
 I 227** (24.4) 337** (33.2)
 II 215 (23.1) 229 (22.6)
 III 270** (29.0) 227** (22.4)
 IV 218 (23.4) 221 (21.8)
Received surgery 842 (90.5) 936 (92.3)
Waiting time from diagnosis to surgery, d
 < 14 610** (73.8) 609** (67.4)
 14–29 125** (15.1) 205** (22.7)
 30–59 58 (7.0) 69 (7.6)
 ≥60 33** (4.0) 20** (2.2)
 Missing data 16** (1.9) 33** (3.5)
Received chemotherapy 266 (28.6) 316 (31.7)
Missing data for receipt of chemotherapy 0** (0.0) 16** (1.6)
Wait time for chemotherapy
 Had chemotherapy before surgery 24 (11.3) 43 (14.0)
 < 30 d after surgery 32** (15.1) 77** (25.1)
 30–59 d after surgery 86 (40.6) 133 (43.3)
 ≥60 d after surgery 70** (33.0) 54** (17.6)
 Missing data 54** (20.3) 33** (10.7)
No. of regional lymph nodes examined
 < 6 304** (41.1) 274** (30.3)
 6–11 282** (38.1) 312** (34.6)
 12–15 68** (9.2) 151** (16.7)
 ≥16 86** (11.6) 166** (18.4)
 Missing data 102** (12.1) 33** (3.5)
Survived 5 y from diagnosis 463 (49.8) 516 (50.9)
a

American Joint Committee on Cancer staging.34

**

P < .05 for between-country difference (χ2 test).